Cart
sales@molnova.com
Aplodan
CAS No. 6903-79-3
Aplodan( Creatinolfosfate | Nergize | Creatinolfosfate, Creatinol Phosphate | creatinol-O-phosphate )
Catalog No. M27339 CAS No. 6903-79-3
Aplodan exhibits antiischemic and antiarrhythmic capacity and protective action on the cell membrane.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 38 | In Stock |
|
| 50MG | 59 | In Stock |
|
| 100MG | 83 | In Stock |
|
| 200MG | 123 | In Stock |
|
| 500MG | 214 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAplodan
-
NoteResearch use only, not for human use.
-
Brief DescriptionAplodan exhibits antiischemic and antiarrhythmic capacity and protective action on the cell membrane.
-
DescriptionAplodan exhibits antiischemic and antiarrhythmic capacity and protective action on the cell membrane. Aplodan can be used in research on the ischemic heart or ischemic heart disease with persistent ventricular premature beats.
-
In Vitro——
-
In Vivo——
-
SynonymsCreatinolfosfate | Nergize | Creatinolfosfate, Creatinol Phosphate | creatinol-O-phosphate
-
PathwayOthers
-
TargetOther Targets
-
RecptorD2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6903-79-3
-
Formula Weight197.131
-
Molecular FormulaC4H12N3O4P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 62.5 mg/mL (317.05 mM)
-
SMILESCN(CCOP(O)(O)=O)C(N)=N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Haase AF, et al. Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist. Naunyn Schmiedebergs Arch Pharmacol. 1991 Jun;343(6):588-94.
molnova catalog
related products
-
Hexadecyl prop-2-eno...
Hexadecyl prop-2-enoate (Hexadecyl acrylate) is an important industrial raw material that can be used in coatings, adhesives, plastics, rubber and other fields.
-
Poly(D,L-lactide-co-...
Poly(D,L-lactide-co-glycolide)
-
JMJD6 inhibitor WL12
2H-1-Benzopyran-2-one, 3-(3H-imidazo[4,5-c]pyridin-2-yl)-6-methyl- is a first-in-class JMJD6 inhibitor and was shown to be able to suppress JMJD6-dependent cancer cell proliferation including cervical and liver cancer cells.
